

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation by symbiont of host defense response (GO:0052509) | 5.52214878 |
| 2 | modulation by symbiont of host defense response (GO:0052031) | 5.52214878 |
| 3 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.52214878 |
| 4 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.52214878 |
| 5 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.52214878 |
| 6 | modulation by symbiont of host immune response (GO:0052553) | 5.52214878 |
| 7 | response to peptidoglycan (GO:0032494) | 5.25886735 |
| 8 | regulation of cholesterol esterification (GO:0010872) | 5.20410842 |
| 9 | neutrophil activation involved in immune response (GO:0002283) | 5.02728787 |
| 10 | macrophage activation involved in immune response (GO:0002281) | 4.96512404 |
| 11 | detection of other organism (GO:0098543) | 4.76835914 |
| 12 | negative regulation of interleukin-12 production (GO:0032695) | 4.75768820 |
| 13 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.71553982 |
| 14 | detection of bacterium (GO:0016045) | 4.60476388 |
| 15 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.52764082 |
| 16 | immunoglobulin mediated immune response (GO:0016064) | 4.48527629 |
| 17 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.30349629 |
| 18 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.25003233 |
| 19 | L-phenylalanine catabolic process (GO:0006559) | 4.25003233 |
| 20 | indole-containing compound catabolic process (GO:0042436) | 4.23151955 |
| 21 | indolalkylamine catabolic process (GO:0046218) | 4.23151955 |
| 22 | tryptophan catabolic process (GO:0006569) | 4.23151955 |
| 23 | aromatic amino acid family catabolic process (GO:0009074) | 4.20957322 |
| 24 | detection of external biotic stimulus (GO:0098581) | 4.12948560 |
| 25 | cellular extravasation (GO:0045123) | 4.12688524 |
| 26 | detection of molecule of bacterial origin (GO:0032490) | 4.12430667 |
| 27 | sulfur amino acid catabolic process (GO:0000098) | 4.10514567 |
| 28 | L-phenylalanine metabolic process (GO:0006558) | 4.02146124 |
| 29 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.02146124 |
| 30 | kynurenine metabolic process (GO:0070189) | 4.00757148 |
| 31 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.00121592 |
| 32 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.99247838 |
| 33 | high-density lipoprotein particle remodeling (GO:0034375) | 3.96632262 |
| 34 | regulation of gamma-delta T cell activation (GO:0046643) | 3.96585529 |
| 35 | phospholipid efflux (GO:0033700) | 3.93065712 |
| 36 | response to host immune response (GO:0052572) | 3.88566344 |
| 37 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.88566344 |
| 38 | tryptophan metabolic process (GO:0006568) | 3.88007724 |
| 39 | alpha-linolenic acid metabolic process (GO:0036109) | 3.83986048 |
| 40 | respiratory burst (GO:0045730) | 3.79526932 |
| 41 | urea metabolic process (GO:0019627) | 3.77731032 |
| 42 | urea cycle (GO:0000050) | 3.77731032 |
| 43 | germinal center formation (GO:0002467) | 3.77136436 |
| 44 | neutrophil activation (GO:0042119) | 3.71696867 |
| 45 | reverse cholesterol transport (GO:0043691) | 3.67916445 |
| 46 | regulation of mast cell degranulation (GO:0043304) | 3.67438281 |
| 47 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.66818443 |
| 48 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.66818443 |
| 49 | cellular response to type I interferon (GO:0071357) | 3.64747969 |
| 50 | type I interferon signaling pathway (GO:0060337) | 3.64747969 |
| 51 | microglial cell activation (GO:0001774) | 3.64207433 |
| 52 | myeloid cell activation involved in immune response (GO:0002275) | 3.63896996 |
| 53 | detection of biotic stimulus (GO:0009595) | 3.63513423 |
| 54 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.62724720 |
| 55 | negative regulation of sterol transport (GO:0032372) | 3.61977734 |
| 56 | negative regulation of cholesterol transport (GO:0032375) | 3.61977734 |
| 57 | response to type I interferon (GO:0034340) | 3.61760940 |
| 58 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.61451822 |
| 59 | granulocyte activation (GO:0036230) | 3.60563585 |
| 60 | response to muramyl dipeptide (GO:0032495) | 3.59227170 |
| 61 | regulation of triglyceride catabolic process (GO:0010896) | 3.59161583 |
| 62 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.56248411 |
| 63 | macrophage activation (GO:0042116) | 3.55718688 |
| 64 | protein-lipid complex remodeling (GO:0034368) | 3.55377483 |
| 65 | macromolecular complex remodeling (GO:0034367) | 3.55377483 |
| 66 | plasma lipoprotein particle remodeling (GO:0034369) | 3.55377483 |
| 67 | B cell receptor signaling pathway (GO:0050853) | 3.54497002 |
| 68 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.53180305 |
| 69 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.51551258 |
| 70 | response to host (GO:0075136) | 3.50717958 |
| 71 | response to host defenses (GO:0052200) | 3.50717958 |
| 72 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.50717958 |
| 73 | cysteine metabolic process (GO:0006534) | 3.50644836 |
| 74 | complement activation, alternative pathway (GO:0006957) | 3.48525417 |
| 75 | B cell mediated immunity (GO:0019724) | 3.48420897 |
| 76 | glyoxylate metabolic process (GO:0046487) | 3.44745647 |
| 77 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.44364960 |
| 78 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.43288359 |
| 79 | nitrogen cycle metabolic process (GO:0071941) | 3.42832427 |
| 80 | defense response to protozoan (GO:0042832) | 3.41247904 |
| 81 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.39554445 |
| 82 | protein carboxylation (GO:0018214) | 3.39554445 |
| 83 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.37439207 |
| 84 | negative regulation of T cell mediated immunity (GO:0002710) | 3.33687792 |
| 85 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.33471369 |
| 86 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.33390127 |
| 87 | bile acid biosynthetic process (GO:0006699) | 3.33098841 |
| 88 | positive regulation of mast cell activation (GO:0033005) | 3.30551557 |
| 89 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.28213362 |
| 90 | plasma lipoprotein particle assembly (GO:0034377) | 3.27197464 |
| 91 | regulation of leukocyte degranulation (GO:0043300) | 3.26249763 |
| 92 | phospholipid homeostasis (GO:0055091) | 3.25562826 |
| 93 | regulation of antigen processing and presentation (GO:0002577) | 3.25472710 |
| 94 | positive regulation of type 2 immune response (GO:0002830) | 3.25313982 |
| 95 | positive regulation of B cell differentiation (GO:0045579) | 3.23994433 |
| 96 | low-density lipoprotein particle remodeling (GO:0034374) | 3.22539824 |
| 97 | regulation of mast cell activation (GO:0033003) | 3.22347160 |
| 98 | cholesterol efflux (GO:0033344) | 3.22044798 |
| 99 | plasma lipoprotein particle clearance (GO:0034381) | 3.21992494 |
| 100 | positive regulation of antigen processing and presentation (GO:0002579) | 3.20231660 |
| 101 | T-helper 1 type immune response (GO:0042088) | 3.20218728 |
| 102 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.19763750 |
| 103 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.19586280 |
| 104 | cellular modified amino acid catabolic process (GO:0042219) | 3.17716165 |
| 105 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.16509915 |
| 106 | neutrophil mediated immunity (GO:0002446) | 3.16096105 |
| 107 | response to protozoan (GO:0001562) | 3.15658751 |
| 108 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.13156399 |
| 109 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.12754298 |
| 110 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.12147953 |
| 111 | positive regulation of interferon-alpha production (GO:0032727) | 3.11117840 |
| 112 | regulation of T cell tolerance induction (GO:0002664) | 3.11090283 |
| 113 | homocysteine metabolic process (GO:0050667) | 3.10890514 |
| 114 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.10116933 |
| 115 | regulation of cholesterol homeostasis (GO:2000188) | 3.09034848 |
| 116 | leukocyte aggregation (GO:0070486) | 3.07587200 |
| 117 | regulation of interferon-alpha production (GO:0032647) | 3.06514274 |
| 118 | regulation of tolerance induction (GO:0002643) | 3.05918592 |
| 119 | bile acid and bile salt transport (GO:0015721) | 3.03503521 |
| 120 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.03071585 |
| 121 | positive regulation of mast cell degranulation (GO:0043306) | 3.02359687 |
| 122 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.02359687 |
| 123 | regulation of protein activation cascade (GO:2000257) | 3.02099010 |
| 124 | regulation of B cell differentiation (GO:0045577) | 3.01208398 |
| 125 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.01180364 |
| 126 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.01180364 |
| 127 | plasma lipoprotein particle organization (GO:0071827) | 3.00433467 |
| 128 | NIK/NF-kappaB signaling (GO:0038061) | 2.98001348 |
| 129 | protein-lipid complex assembly (GO:0065005) | 2.97394788 |
| 130 | bile acid metabolic process (GO:0008206) | 2.96502913 |
| 131 | amino-acid betaine metabolic process (GO:0006577) | 2.95514720 |
| 132 | negative regulation of fibrinolysis (GO:0051918) | 2.94113047 |
| 133 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.93683311 |
| 134 | regulation of cholesterol transport (GO:0032374) | 2.93496014 |
| 135 | regulation of sterol transport (GO:0032371) | 2.93496014 |
| 136 | cholesterol homeostasis (GO:0042632) | 2.92176360 |
| 137 | serine family amino acid catabolic process (GO:0009071) | 2.89789172 |
| 138 | drug catabolic process (GO:0042737) | 2.89715877 |
| 139 | sterol homeostasis (GO:0055092) | 2.88935276 |
| 140 | intestinal cholesterol absorption (GO:0030299) | 2.88847371 |
| 141 | response to interleukin-15 (GO:0070672) | 2.88255337 |
| 142 | aromatic amino acid family metabolic process (GO:0009072) | 2.87339066 |
| 143 | indolalkylamine metabolic process (GO:0006586) | 2.87334386 |
| 144 | lysine catabolic process (GO:0006554) | 2.86979797 |
| 145 | lysine metabolic process (GO:0006553) | 2.86979797 |
| 146 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.86264875 |
| 147 | positive thymic T cell selection (GO:0045059) | 2.86066359 |
| 148 | positive regulation of lipid catabolic process (GO:0050996) | 2.85352823 |
| 149 | acute-phase response (GO:0006953) | 2.84919002 |
| 150 | protein-lipid complex subunit organization (GO:0071825) | 2.84855397 |
| 151 | regulation of fibrinolysis (GO:0051917) | 2.84054565 |
| 152 | amine catabolic process (GO:0009310) | 2.82733406 |
| 153 | cellular biogenic amine catabolic process (GO:0042402) | 2.82733406 |
| 154 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.82614433 |
| 155 | regulation of type 2 immune response (GO:0002828) | 2.82451310 |
| 156 | negative regulation of interleukin-6 production (GO:0032715) | 2.81557723 |
| 157 | regulation of complement activation (GO:0030449) | 2.81496714 |
| 158 | regulation of regulated secretory pathway (GO:1903305) | 2.81021045 |
| 159 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.80874267 |
| 160 | myeloid leukocyte activation (GO:0002274) | 2.79492217 |
| 161 | leukocyte degranulation (GO:0043299) | 2.79442924 |
| 162 | myeloid leukocyte mediated immunity (GO:0002444) | 2.79440968 |
| 163 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.79248586 |
| 164 | killing of cells of other organism (GO:0031640) | 2.78595760 |
| 165 | disruption of cells of other organism (GO:0044364) | 2.78595760 |
| 166 | lymphocyte chemotaxis (GO:0048247) | 2.78470227 |
| 167 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.77067850 |
| 168 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.76639332 |
| 169 | flavonoid metabolic process (GO:0009812) | 2.76472216 |
| 170 | acylglycerol homeostasis (GO:0055090) | 2.75656980 |
| 171 | triglyceride homeostasis (GO:0070328) | 2.75656980 |
| 172 | cellular response to interferon-gamma (GO:0071346) | 2.75479250 |
| 173 | valine metabolic process (GO:0006573) | 2.75362939 |
| 174 | negative regulation of cell killing (GO:0031342) | 2.74299253 |
| 175 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.74299253 |
| 176 | T cell migration (GO:0072678) | 2.70803478 |
| 177 | cellular glucuronidation (GO:0052695) | 2.70210348 |
| 178 | aldehyde catabolic process (GO:0046185) | 2.69189308 |
| 179 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.69164322 |
| 180 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.69164322 |
| 181 | glutamate metabolic process (GO:0006536) | 2.67874682 |
| 182 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.67452254 |
| 183 | alpha-amino acid catabolic process (GO:1901606) | 2.65769365 |
| 184 | ethanol oxidation (GO:0006069) | 2.65639283 |
| 185 | benzene-containing compound metabolic process (GO:0042537) | 2.64492390 |
| 186 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.62779660 |
| 187 | lipoprotein metabolic process (GO:0042157) | 2.61490730 |
| 188 | drug transmembrane transport (GO:0006855) | 2.61276649 |
| 189 | cellular ketone body metabolic process (GO:0046950) | 2.60217245 |
| 190 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.59723254 |
| 191 | urate metabolic process (GO:0046415) | 2.58657535 |
| 192 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.57630422 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.47348375 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.74921825 |
| 3 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.37163986 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.96841753 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.82900330 |
| 6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.64399583 |
| 7 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.39103139 |
| 8 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.34422112 |
| 9 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.19745596 |
| 10 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.12426002 |
| 11 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.72634507 |
| 12 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.71691097 |
| 13 | MYC_22102868_ChIP-Seq_BL_Human | 2.65589646 |
| 14 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.49829220 |
| 15 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.46721238 |
| 16 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.31801841 |
| 17 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.31425162 |
| 18 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.27319632 |
| 19 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.25502204 |
| 20 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.18416677 |
| 21 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.16515975 |
| 22 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.09367308 |
| 23 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.98389201 |
| 24 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.98334790 |
| 25 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.95477047 |
| 26 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.94326547 |
| 27 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.89484201 |
| 28 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.88567120 |
| 29 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.75064300 |
| 30 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.72784111 |
| 31 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.69171571 |
| 32 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.63581594 |
| 33 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.63078348 |
| 34 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.61155544 |
| 35 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.54945156 |
| 36 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53028822 |
| 37 | MAF_26560356_Chip-Seq_TH1_Human | 1.51846022 |
| 38 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.50104318 |
| 39 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.44921477 |
| 40 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.43756194 |
| 41 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40871902 |
| 42 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.38858561 |
| 43 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.37958404 |
| 44 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.37672807 |
| 45 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.30782280 |
| 46 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.30093891 |
| 47 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.27884152 |
| 48 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.27707637 |
| 49 | MYB_26560356_Chip-Seq_TH2_Human | 1.26215172 |
| 50 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.24995709 |
| 51 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.24162549 |
| 52 | MYB_26560356_Chip-Seq_TH1_Human | 1.23731297 |
| 53 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.23427138 |
| 54 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.22542002 |
| 55 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.20700140 |
| 56 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.20691791 |
| 57 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.19723182 |
| 58 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.18833355 |
| 59 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.17771205 |
| 60 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.16339241 |
| 61 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.14857341 |
| 62 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.14597336 |
| 63 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.12648159 |
| 64 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.11183221 |
| 65 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.11053703 |
| 66 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.10278171 |
| 67 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.10069176 |
| 68 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.09911103 |
| 69 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.09382067 |
| 70 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.09369934 |
| 71 | UTX_26944678_Chip-Seq_JUKART_Human | 1.08838695 |
| 72 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.07822487 |
| 73 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.07647770 |
| 74 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07198533 |
| 75 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.06865978 |
| 76 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.06239633 |
| 77 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.04186345 |
| 78 | GATA1_22025678_ChIP-Seq_K562_Human | 1.04132955 |
| 79 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.04082145 |
| 80 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.03667561 |
| 81 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.03181888 |
| 82 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.03154300 |
| 83 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02829152 |
| 84 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.02388866 |
| 85 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.02372171 |
| 86 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.02191985 |
| 87 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.02071118 |
| 88 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.01263982 |
| 89 | SPI1_23127762_ChIP-Seq_K562_Human | 1.00931596 |
| 90 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99825038 |
| 91 | GATA2_19941826_ChIP-Seq_K562_Human | 0.97520391 |
| 92 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.94802178 |
| 93 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.93472552 |
| 94 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.92268101 |
| 95 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.91856525 |
| 96 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.89680277 |
| 97 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.89424326 |
| 98 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89268973 |
| 99 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.89152333 |
| 100 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.89102163 |
| 101 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.89025949 |
| 102 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.88925485 |
| 103 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.88886736 |
| 104 | * PU_27001747_Chip-Seq_BMDM_Mouse | 0.88102181 |
| 105 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.87843223 |
| 106 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.87101464 |
| 107 | GATA1_19941826_ChIP-Seq_K562_Human | 0.86549747 |
| 108 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.86198910 |
| 109 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.85823733 |
| 110 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.85431273 |
| 111 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.85102008 |
| 112 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.85053951 |
| 113 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.84849401 |
| 114 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.84702377 |
| 115 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.84432200 |
| 116 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.83920270 |
| 117 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.83733155 |
| 118 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.83665223 |
| 119 | GATA3_26560356_Chip-Seq_TH2_Human | 0.83079140 |
| 120 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.83053057 |
| 121 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.82740565 |
| 122 | * CLOCK_20551151_ChIP-Seq_293T_Human | 0.82154129 |
| 123 | * MAF_26560356_Chip-Seq_TH2_Human | 0.80656617 |
| 124 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.78615296 |
| 125 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.77580470 |
| 126 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.77482682 |
| 127 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.76499113 |
| 128 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.76360309 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 5.35895603 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 4.90882193 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 3.63303789 |
| 4 | MP0005365_abnormal_bile_salt | 3.57982423 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 3.18181318 |
| 6 | MP0009840_abnormal_foam_cell | 3.04135601 |
| 7 | MP0003436_decreased_susceptibility_to | 2.75723962 |
| 8 | MP0002138_abnormal_hepatobiliary_system | 2.56437230 |
| 9 | MP0003252_abnormal_bile_duct | 2.55654853 |
| 10 | MP0002254_reproductive_system_inflammat | 2.49468285 |
| 11 | MP0010329_abnormal_lipoprotein_level | 2.42788657 |
| 12 | MP0009785_altered_susceptibility_to | 2.41074902 |
| 13 | * MP0001835_abnormal_antigen_presentation | 2.36434023 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.26757580 |
| 15 | MP0001666_abnormal_nutrient_absorption | 2.11010183 |
| 16 | MP0000685_abnormal_immune_system | 2.07025789 |
| 17 | MP0006082_CNS_inflammation | 2.06299688 |
| 18 | MP0005332_abnormal_amino_acid | 2.04729012 |
| 19 | MP0005025_abnormal_response_to | 2.02414021 |
| 20 | MP0002419_abnormal_innate_immunity | 1.95311368 |
| 21 | MP0005083_abnormal_biliary_tract | 1.93544694 |
| 22 | MP0009764_decreased_sensitivity_to | 1.92243243 |
| 23 | MP0001790_abnormal_immune_system | 1.90139610 |
| 24 | MP0005387_immune_system_phenotype | 1.90139610 |
| 25 | MP0003303_peritoneal_inflammation | 1.89572754 |
| 26 | MP0005671_abnormal_response_to | 1.86897694 |
| 27 | MP0009278_abnormal_bone_marrow | 1.81685048 |
| 28 | MP0005000_abnormal_immune_tolerance | 1.79602050 |
| 29 | MP0004019_abnormal_vitamin_homeostasis | 1.75486627 |
| 30 | MP0008260_abnormal_autophagy | 1.75059670 |
| 31 | MP0003724_increased_susceptibility_to | 1.74945553 |
| 32 | MP0001800_abnormal_humoral_immune | 1.73937359 |
| 33 | MP0003806_abnormal_nucleotide_metabolis | 1.72727136 |
| 34 | MP0004947_skin_inflammation | 1.72631021 |
| 35 | MP0000609_abnormal_liver_physiology | 1.71051920 |
| 36 | MP0000604_amyloidosis | 1.64977423 |
| 37 | * MP0002148_abnormal_hypersensitivity_rea | 1.63979990 |
| 38 | MP0005058_abnormal_lysosome_morphology | 1.63733616 |
| 39 | MP0005464_abnormal_platelet_physiology | 1.63434236 |
| 40 | MP0008469_abnormal_protein_level | 1.56112987 |
| 41 | MP0003300_gastrointestinal_ulcer | 1.55351653 |
| 42 | * MP0002723_abnormal_immune_serum | 1.54400946 |
| 43 | * MP0002452_abnormal_antigen_presenting | 1.52685704 |
| 44 | MP0005310_abnormal_salivary_gland | 1.50320747 |
| 45 | MP0010155_abnormal_intestine_physiology | 1.49184987 |
| 46 | MP0001845_abnormal_inflammatory_respons | 1.48723994 |
| 47 | * MP0001819_abnormal_immune_cell | 1.42618069 |
| 48 | MP0002118_abnormal_lipid_homeostasis | 1.41715241 |
| 49 | MP0005319_abnormal_enzyme/_coenzyme | 1.41110479 |
| 50 | MP0003195_calcinosis | 1.40496941 |
| 51 | * MP0002420_abnormal_adaptive_immunity | 1.40302669 |
| 52 | MP0000465_gastrointestinal_hemorrhage | 1.38002412 |
| 53 | MP0003828_pulmonary_edema | 1.37629872 |
| 54 | MP0001853_heart_inflammation | 1.36920527 |
| 55 | MP0009643_abnormal_urine_homeostasis | 1.36888750 |
| 56 | MP0005451_abnormal_body_composition | 1.35666806 |
| 57 | MP0010234_abnormal_vibrissa_follicle | 1.32572122 |
| 58 | MP0003075_altered_response_to | 1.31458695 |
| 59 | MP0001873_stomach_inflammation | 1.31013628 |
| 60 | MP0001545_abnormal_hematopoietic_system | 1.30940729 |
| 61 | MP0005397_hematopoietic_system_phenotyp | 1.30940729 |
| 62 | MP0002998_abnormal_bone_remodeling | 1.30927123 |
| 63 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.30781930 |
| 64 | MP0002166_altered_tumor_susceptibility | 1.29216537 |
| 65 | MP0002405_respiratory_system_inflammati | 1.25339759 |
| 66 | MP0002396_abnormal_hematopoietic_system | 1.25230545 |
| 67 | MP0003183_abnormal_peptide_metabolism | 1.22090351 |
| 68 | MP0004510_myositis | 1.21901622 |
| 69 | MP0002006_tumorigenesis | 1.18801478 |
| 70 | MP0001533_abnormal_skeleton_physiology | 1.16762332 |
| 71 | MP0000703_abnormal_thymus_morphology | 1.15859814 |
| 72 | MP0009763_increased_sensitivity_to | 1.10419313 |
| 73 | MP0005166_decreased_susceptibility_to | 1.09767111 |
| 74 | MP0004883_abnormal_blood_vessel | 1.04480966 |
| 75 | MP0008004_abnormal_stomach_pH | 1.04004196 |
| 76 | MP0003866_abnormal_defecation | 1.03394678 |
| 77 | MP0004381_abnormal_hair_follicle | 1.03320162 |
| 78 | MP0001851_eye_inflammation | 1.02607370 |
| 79 | * MP0000716_abnormal_immune_system | 1.02555671 |
| 80 | MP0002277_abnormal_respiratory_mucosa | 1.01364677 |
| 81 | MP0003705_abnormal_hypodermis_morpholog | 1.01154653 |
| 82 | MP0005167_abnormal_blood-brain_barrier | 1.00274217 |
| 83 | MP0003186_abnormal_redox_activity | 0.99281602 |
| 84 | MP0002136_abnormal_kidney_physiology | 0.99036254 |
| 85 | MP0003329_amyloid_beta_deposits | 0.98937293 |
| 86 | MP0003690_abnormal_glial_cell | 0.97258453 |
| 87 | MP0005636_abnormal_mineral_homeostasis | 0.96336473 |
| 88 | MP0003763_abnormal_thymus_physiology | 0.95252557 |
| 89 | MP0009765_abnormal_xenobiotic_induced | 0.94202933 |
| 90 | MP0003172_abnormal_lysosome_physiology | 0.93697579 |
| 91 | MP0000858_altered_metastatic_potential | 0.90145421 |
| 92 | MP0004808_abnormal_hematopoietic_stem | 0.88039127 |
| 93 | * MP0002398_abnormal_bone_marrow | 0.86947956 |
| 94 | MP0002933_joint_inflammation | 0.84566601 |
| 95 | MP0000598_abnormal_liver_morphology | 0.82972671 |
| 96 | MP0001764_abnormal_homeostasis | 0.82772360 |
| 97 | MP0003453_abnormal_keratinocyte_physiol | 0.82730545 |
| 98 | MP0005164_abnormal_response_to | 0.81427315 |
| 99 | MP0002132_abnormal_respiratory_system | 0.81097272 |
| 100 | MP0000689_abnormal_spleen_morphology | 0.80962508 |
| 101 | MP0009642_abnormal_blood_homeostasis | 0.79380971 |
| 102 | * MP0002429_abnormal_blood_cell | 0.78440215 |
| 103 | MP0002722_abnormal_immune_system | 0.77886545 |
| 104 | MP0001765_abnormal_ion_homeostasis | 0.77201410 |
| 105 | MP0003656_abnormal_erythrocyte_physiolo | 0.76782083 |
| 106 | MP0004264_abnormal_extraembryonic_tissu | 0.75995592 |
| 107 | MP0003448_altered_tumor_morphology | 0.75853092 |
| 108 | MP0000343_altered_response_to | 0.75047510 |
| 109 | MP0004782_abnormal_surfactant_physiolog | 0.73934348 |
| 110 | MP0005390_skeleton_phenotype | 0.73508403 |
| 111 | MP0008874_decreased_physiological_sensi | 0.72582230 |
| 112 | MP0001663_abnormal_digestive_system | 0.70752228 |
| 113 | MP0003045_fibrosis | 0.69754509 |
| 114 | MP0003868_abnormal_feces_composition | 0.69653608 |
| 115 | MP0009333_abnormal_splenocyte_physiolog | 0.68905370 |
| 116 | MP0003011_delayed_dark_adaptation | 0.68393522 |
| 117 | MP0002796_impaired_skin_barrier | 0.68375005 |
| 118 | MP0000490_abnormal_crypts_of | 0.67477531 |
| 119 | MP0005647_abnormal_sex_gland | 0.66984696 |
| 120 | MP0001756_abnormal_urination | 0.66966066 |
| 121 | MP0005535_abnormal_body_temperature | 0.66840414 |
| 122 | MP0003795_abnormal_bone_structure | 0.64732543 |
| 123 | MP0005076_abnormal_cell_differentiation | 0.64165870 |
| 124 | MP0000920_abnormal_myelination | 0.63268969 |
| 125 | MP0003221_abnormal_cardiomyocyte_apopto | 0.60582258 |
| 126 | MP0003091_abnormal_cell_migration | 0.60453209 |
| 127 | MP0002332_abnormal_exercise_endurance | 0.59980856 |
| 128 | MP0000249_abnormal_blood_vessel | 0.59269870 |
| 129 | MP0000015_abnormal_ear_pigmentation | 0.56387828 |
| 130 | MP0000371_diluted_coat_color | 0.53504039 |
| 131 | MP0005075_abnormal_melanosome_morpholog | 0.53445375 |
| 132 | MP0002693_abnormal_pancreas_physiology | 0.53186321 |
| 133 | MP0005381_digestive/alimentary_phenotyp | 0.51678633 |
| 134 | MP0002019_abnormal_tumor_incidence | 0.45622123 |
| 135 | MP0002009_preneoplasia | 0.45317563 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.74524376 |
| 2 | Eczematoid dermatitis (HP:0000976) | 4.64751892 |
| 3 | Retrobulbar optic neuritis (HP:0100654) | 4.63930315 |
| 4 | Optic neuritis (HP:0100653) | 4.63930315 |
| 5 | Xanthomatosis (HP:0000991) | 4.34206128 |
| 6 | Deep venous thrombosis (HP:0002625) | 4.32515736 |
| 7 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.10948237 |
| 8 | Meningitis (HP:0001287) | 4.05417062 |
| 9 | Intrahepatic cholestasis (HP:0001406) | 4.01028397 |
| 10 | Joint hemorrhage (HP:0005261) | 3.99516664 |
| 11 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.90540877 |
| 12 | Prolonged partial thromboplastin time (HP:0003645) | 3.88619676 |
| 13 | Recurrent bacterial skin infections (HP:0005406) | 3.78797040 |
| 14 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.78571904 |
| 15 | Recurrent abscess formation (HP:0002722) | 3.77400307 |
| 16 | Abnormality of glycolipid metabolism (HP:0010969) | 3.71445096 |
| 17 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.71445096 |
| 18 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.71445096 |
| 19 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.64390146 |
| 20 | Hypobetalipoproteinemia (HP:0003563) | 3.48308574 |
| 21 | Complement deficiency (HP:0004431) | 3.45571465 |
| 22 | Increased cerebral lipofuscin (HP:0011813) | 3.43006186 |
| 23 | Hyperlipoproteinemia (HP:0010980) | 3.42154368 |
| 24 | Keratoconjunctivitis sicca (HP:0001097) | 3.40520350 |
| 25 | Systemic lupus erythematosus (HP:0002725) | 3.38302148 |
| 26 | Encephalitis (HP:0002383) | 3.35111400 |
| 27 | Abnormality of the common coagulation pathway (HP:0010990) | 3.32514089 |
| 28 | Cellulitis (HP:0100658) | 3.23392978 |
| 29 | Autoimmune thrombocytopenia (HP:0001973) | 3.15605115 |
| 30 | Keratoconjunctivitis (HP:0001096) | 3.11122849 |
| 31 | Pulmonary infiltrates (HP:0002113) | 3.07956116 |
| 32 | Myocardial infarction (HP:0001658) | 3.02464089 |
| 33 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.98392832 |
| 34 | Hemoptysis (HP:0002105) | 2.97787028 |
| 35 | Abnormality of macrophages (HP:0004311) | 2.93761121 |
| 36 | Gingival bleeding (HP:0000225) | 2.93630288 |
| 37 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.91558520 |
| 38 | Loss of speech (HP:0002371) | 2.91551362 |
| 39 | Gingivitis (HP:0000230) | 2.89786886 |
| 40 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.87011225 |
| 41 | Hyperglycinuria (HP:0003108) | 2.86464561 |
| 42 | Recurrent skin infections (HP:0001581) | 2.85822842 |
| 43 | Chest pain (HP:0100749) | 2.84807891 |
| 44 | Recurrent fungal infections (HP:0002841) | 2.84603677 |
| 45 | Gastrointestinal stroma tumor (HP:0100723) | 2.83860479 |
| 46 | Inflammation of the large intestine (HP:0002037) | 2.81241238 |
| 47 | Vacuolated lymphocytes (HP:0001922) | 2.80090533 |
| 48 | Amyloidosis (HP:0011034) | 2.78106735 |
| 49 | Abnormality of complement system (HP:0005339) | 2.77842086 |
| 50 | Dysostosis multiplex (HP:0000943) | 2.77613447 |
| 51 | Epidermoid cyst (HP:0200040) | 2.76218590 |
| 52 | Gastrointestinal inflammation (HP:0004386) | 2.74983905 |
| 53 | Colitis (HP:0002583) | 2.73067183 |
| 54 | Hyperammonemia (HP:0001987) | 2.72767701 |
| 55 | Fat malabsorption (HP:0002630) | 2.68090457 |
| 56 | Petechiae (HP:0000967) | 2.63732790 |
| 57 | Hypolipoproteinemia (HP:0010981) | 2.62768771 |
| 58 | Hypercholesterolemia (HP:0003124) | 2.61264904 |
| 59 | Pustule (HP:0200039) | 2.60327147 |
| 60 | Prolonged bleeding time (HP:0003010) | 2.59827818 |
| 61 | Mediastinal lymphadenopathy (HP:0100721) | 2.59311732 |
| 62 | Conjugated hyperbilirubinemia (HP:0002908) | 2.55871543 |
| 63 | Premature loss of primary teeth (HP:0006323) | 2.55684678 |
| 64 | Gastrointestinal infarctions (HP:0005244) | 2.55179673 |
| 65 | Increased IgM level (HP:0003496) | 2.54981202 |
| 66 | Osteomyelitis (HP:0002754) | 2.53104347 |
| 67 | Periodontitis (HP:0000704) | 2.51940833 |
| 68 | Lymphopenia (HP:0001888) | 2.51158397 |
| 69 | Agammaglobulinemia (HP:0004432) | 2.50807205 |
| 70 | Glomerulonephritis (HP:0000099) | 2.50667906 |
| 71 | Arterial thrombosis (HP:0004420) | 2.50573839 |
| 72 | Abnormality of purine metabolism (HP:0004352) | 2.50556450 |
| 73 | Myositis (HP:0100614) | 2.48427387 |
| 74 | Ketosis (HP:0001946) | 2.47668165 |
| 75 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.46954567 |
| 76 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.46042789 |
| 77 | Abnormality of glycine metabolism (HP:0010895) | 2.46042789 |
| 78 | Leukocytosis (HP:0001974) | 2.44774158 |
| 79 | Recurrent sinusitis (HP:0011108) | 2.42995159 |
| 80 | Abnormality of proline metabolism (HP:0010907) | 2.42646665 |
| 81 | Hydroxyprolinuria (HP:0003080) | 2.42646665 |
| 82 | Nasal polyposis (HP:0100582) | 2.42585227 |
| 83 | Gangrene (HP:0100758) | 2.42090042 |
| 84 | Disinhibition (HP:0000734) | 2.40013257 |
| 85 | Stomatitis (HP:0010280) | 2.37333949 |
| 86 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.37224825 |
| 87 | Hypergammaglobulinemia (HP:0010702) | 2.37129503 |
| 88 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.36557379 |
| 89 | Purpura (HP:0000979) | 2.35376285 |
| 90 | Hypoalphalipoproteinemia (HP:0003233) | 2.35165146 |
| 91 | IgM deficiency (HP:0002850) | 2.34417592 |
| 92 | Episodic fever (HP:0001954) | 2.33958841 |
| 93 | Esophageal varix (HP:0002040) | 2.33609482 |
| 94 | Urticaria (HP:0001025) | 2.33556231 |
| 95 | Abnormality of nucleobase metabolism (HP:0010932) | 2.32727482 |
| 96 | Joint swelling (HP:0001386) | 2.32615452 |
| 97 | Orchitis (HP:0100796) | 2.32139102 |
| 98 | Panhypogammaglobulinemia (HP:0003139) | 2.31286995 |
| 99 | Abnormality of the pleura (HP:0002103) | 2.31134094 |
| 100 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.30898603 |
| 101 | Abnormality of T cells (HP:0002843) | 2.30729929 |
| 102 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.30662745 |
| 103 | Hypochromic anemia (HP:0001931) | 2.30091365 |
| 104 | Menorrhagia (HP:0000132) | 2.28077807 |
| 105 | Restrictive lung disease (HP:0002091) | 2.27935659 |
| 106 | Sepsis (HP:0100806) | 2.27352268 |
| 107 | Recurrent viral infections (HP:0004429) | 2.26812960 |
| 108 | Recurrent bronchitis (HP:0002837) | 2.22843159 |
| 109 | Abnormality of the intrinsic pathway (HP:0010989) | 2.22734432 |
| 110 | Hemorrhage of the eye (HP:0011885) | 2.22403297 |
| 111 | Increased serum ferritin (HP:0003281) | 2.18093500 |
| 112 | Vasculitis (HP:0002633) | 2.17840448 |
| 113 | Malnutrition (HP:0004395) | 2.17759610 |
| 114 | Abnormality of T cell physiology (HP:0011840) | 2.17545061 |
| 115 | Epistaxis (HP:0000421) | 2.17452525 |
| 116 | Recurrent pneumonia (HP:0006532) | 2.16823814 |
| 117 | Granulocytopenia (HP:0001913) | 2.13909167 |
| 118 | Abnormality of T cell number (HP:0011839) | 2.10754352 |
| 119 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.09712941 |
| 120 | Hepatosplenomegaly (HP:0001433) | 2.09605216 |
| 121 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.09143856 |
| 122 | Recurrent cutaneous fungal infections (HP:0011370) | 2.09143856 |
| 123 | Generalized aminoaciduria (HP:0002909) | 2.07773849 |
| 124 | Hypoglycemic coma (HP:0001325) | 2.07745528 |
| 125 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.06556553 |
| 126 | Abnormality of the nasal mucosa (HP:0000433) | 2.06102106 |
| 127 | Vascular calcification (HP:0004934) | 2.05703772 |
| 128 | Hypochromic microcytic anemia (HP:0004840) | 2.04707596 |
| 129 | Pulmonary embolism (HP:0002204) | 2.04478689 |
| 130 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.04306310 |
| 131 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.04306310 |
| 132 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.04306310 |
| 133 | Polyneuropathy (HP:0001271) | 2.03005719 |
| 134 | Chronic otitis media (HP:0000389) | 2.02485522 |
| 135 | Hyperglycinemia (HP:0002154) | 2.02464928 |
| 136 | Skin ulcer (HP:0200042) | 2.02424601 |
| 137 | Obstructive lung disease (HP:0006536) | 2.00082322 |
| 138 | Chronic obstructive pulmonary disease (HP:0006510) | 2.00082322 |
| 139 | Thrombophlebitis (HP:0004418) | 2.00011335 |
| 140 | Nephritis (HP:0000123) | 1.99888979 |
| 141 | Hepatocellular carcinoma (HP:0001402) | 1.99739846 |
| 142 | Hyperbilirubinemia (HP:0002904) | 1.99562184 |
| 143 | Increased IgE level (HP:0003212) | 1.99044276 |
| 144 | Pancreatitis (HP:0001733) | 1.98826727 |
| 145 | T lymphocytopenia (HP:0005403) | 1.97494059 |
| 146 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.97069545 |
| 147 | Autoimmune hemolytic anemia (HP:0001890) | 1.96399822 |
| 148 | Gout (HP:0001997) | 1.96193809 |
| 149 | Neuronal loss in central nervous system (HP:0002529) | 1.95455348 |
| 150 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.95014333 |
| 151 | Mutism (HP:0002300) | 1.93546290 |
| 152 | Recurrent lower respiratory tract infections (HP:0002783) | 1.93018873 |
| 153 | Vertigo (HP:0002321) | 1.92493005 |
| 154 | Steatorrhea (HP:0002570) | 1.91864675 |
| 155 | Anorexia (HP:0002039) | 1.91534524 |
| 156 | Sensorimotor neuropathy (HP:0007141) | 1.91025090 |
| 157 | Thick nail (HP:0001805) | 1.90992299 |
| 158 | Axonal loss (HP:0003447) | 1.90005450 |
| 159 | Spontaneous abortion (HP:0005268) | 1.89857576 |
| 160 | Ketoacidosis (HP:0001993) | 1.89708389 |
| 161 | Spontaneous hematomas (HP:0007420) | 1.89530818 |
| 162 | Interstitial pulmonary disease (HP:0006530) | 1.87186931 |
| 163 | Entropion (HP:0000621) | 1.86475529 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TAOK3 | 3.74790293 |
| 2 | ERN1 | 3.69748376 |
| 3 | MAP3K14 | 3.16992143 |
| 4 | TYK2 | 2.98461281 |
| 5 | MAP4K1 | 2.85655908 |
| 6 | PRPF4B | 2.79510498 |
| 7 | GRK6 | 2.69500584 |
| 8 | FGFR4 | 2.68460451 |
| 9 | RIPK4 | 2.62763520 |
| 10 | EPHB1 | 2.39177221 |
| 11 | TBK1 | 2.34079326 |
| 12 | IRAK4 | 2.25304071 |
| 13 | JAK3 | 2.18218626 |
| 14 | IKBKE | 2.10771324 |
| 15 | JAK1 | 2.04792027 |
| 16 | BLK | 2.00556276 |
| 17 | IRAK3 | 1.96426171 |
| 18 | TXK | 1.95933654 |
| 19 | MAP3K13 | 1.92232459 |
| 20 | SIK1 | 1.88591772 |
| 21 | CSK | 1.85925431 |
| 22 | MST1R | 1.81044379 |
| 23 | STK10 | 1.59873207 |
| 24 | IRAK2 | 1.55287055 |
| 25 | MST4 | 1.48816897 |
| 26 | ZAP70 | 1.48335913 |
| 27 | IKBKB | 1.47506586 |
| 28 | ITK | 1.43105763 |
| 29 | JAK2 | 1.41182966 |
| 30 | TRIB3 | 1.37544252 |
| 31 | TAOK1 | 1.36824357 |
| 32 | INSRR | 1.34394050 |
| 33 | BCKDK | 1.32016643 |
| 34 | SIK3 | 1.28438955 |
| 35 | PTK6 | 1.26840479 |
| 36 | TAOK2 | 1.25695996 |
| 37 | FGFR3 | 1.24800049 |
| 38 | PKN2 | 1.20054591 |
| 39 | CSF1R | 1.18527100 |
| 40 | MARK2 | 1.15784291 |
| 41 | BTK | 1.13555847 |
| 42 | MAP3K10 | 1.09786336 |
| 43 | GRK7 | 1.04430445 |
| 44 | SYK | 1.02500059 |
| 45 | FES | 1.00825150 |
| 46 | BMPR2 | 0.99748302 |
| 47 | HCK | 0.98662615 |
| 48 | LCK | 0.95938302 |
| 49 | PRKD2 | 0.90419675 |
| 50 | CHUK | 0.89877703 |
| 51 | PRKCQ | 0.89590440 |
| 52 | TGFBR2 | 0.88454108 |
| 53 | YES1 | 0.86355360 |
| 54 | CDC42BPA | 0.85284814 |
| 55 | FGR | 0.84308079 |
| 56 | SMG1 | 0.83881626 |
| 57 | MAP3K7 | 0.82528407 |
| 58 | KSR2 | 0.82065607 |
| 59 | RIPK1 | 0.81061940 |
| 60 | FRK | 0.80960955 |
| 61 | LRRK2 | 0.80183259 |
| 62 | PRKG2 | 0.77450495 |
| 63 | MAP2K2 | 0.76297564 |
| 64 | BMX | 0.72499173 |
| 65 | KIT | 0.71937461 |
| 66 | MAP3K2 | 0.70612183 |
| 67 | PDK1 | 0.70400727 |
| 68 | MAP2K6 | 0.70281299 |
| 69 | LYN | 0.68074502 |
| 70 | PTK2 | 0.67863653 |
| 71 | MAPK11 | 0.66947284 |
| 72 | CDK19 | 0.66917865 |
| 73 | PRKAA2 | 0.63179496 |
| 74 | HIPK2 | 0.62673568 |
| 75 | FLT3 | 0.62294878 |
| 76 | PIK3CG | 0.62248743 |
| 77 | PDPK1 | 0.61937608 |
| 78 | SIK2 | 0.61852670 |
| 79 | TEC | 0.60443422 |
| 80 | MAP3K12 | 0.60065332 |
| 81 | KDR | 0.59651678 |
| 82 | TNK2 | 0.58507420 |
| 83 | MAPK7 | 0.57841647 |
| 84 | TESK2 | 0.56864382 |
| 85 | MAP2K3 | 0.56583645 |
| 86 | CLK1 | 0.54922608 |
| 87 | MAP3K6 | 0.53864577 |
| 88 | PRKCH | 0.53466706 |
| 89 | CAMK1D | 0.51026314 |
| 90 | MAP3K5 | 0.50187224 |
| 91 | MAPK4 | 0.50141246 |
| 92 | PRKCD | 0.49985796 |
| 93 | MARK3 | 0.48491527 |
| 94 | RPS6KC1 | 0.47244228 |
| 95 | RPS6KL1 | 0.47244228 |
| 96 | MAP3K1 | 0.47193464 |
| 97 | CDK12 | 0.46991423 |
| 98 | IRAK1 | 0.45762125 |
| 99 | LMTK2 | 0.42831532 |
| 100 | ABL2 | 0.42738546 |
| 101 | DAPK2 | 0.42316751 |
| 102 | FYN | 0.41343662 |
| 103 | PIM1 | 0.40604966 |
| 104 | MAPK12 | 0.39093679 |
| 105 | MAP3K11 | 0.37742481 |
| 106 | RPS6KA6 | 0.37717863 |
| 107 | MOS | 0.37523974 |
| 108 | MAP3K3 | 0.37330490 |
| 109 | EGFR | 0.37103212 |
| 110 | ARAF | 0.36129470 |
| 111 | MAP2K4 | 0.35560160 |
| 112 | EPHA3 | 0.35544863 |
| 113 | TESK1 | 0.34781229 |
| 114 | SGK2 | 0.34586914 |
| 115 | ABL1 | 0.34549919 |
| 116 | MAP3K8 | 0.34234566 |
| 117 | PRKCZ | 0.33795199 |
| 118 | DYRK1B | 0.33691789 |
| 119 | GRK1 | 0.33105764 |
| 120 | CAMKK1 | 0.32790137 |
| 121 | ACVR1B | 0.32757322 |
| 122 | MATK | 0.32707572 |
| 123 | RAF1 | 0.32669709 |
| 124 | NME2 | 0.32233263 |
| 125 | SGK3 | 0.31362586 |
| 126 | PRKACG | 0.30960569 |
| 127 | RPS6KA2 | 0.30577261 |
| 128 | NLK | 0.30234110 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.19622094 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.02374837 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.95054007 |
| 4 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.80996276 |
| 5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.75183395 |
| 6 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.60640379 |
| 7 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.39721291 |
| 8 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.30709671 |
| 9 | Asthma_Homo sapiens_hsa05310 | 2.25361840 |
| 10 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.24235931 |
| 11 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.22934572 |
| 12 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.96849593 |
| 13 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.86933081 |
| 14 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.73910897 |
| 15 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.72549546 |
| 16 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.72499423 |
| 17 | Histidine metabolism_Homo sapiens_hsa00340 | 1.71206180 |
| 18 | Viral myocarditis_Homo sapiens_hsa05416 | 1.69672146 |
| 19 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.69404559 |
| 20 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.63135154 |
| 21 | Peroxisome_Homo sapiens_hsa04146 | 1.63093077 |
| 22 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.58795762 |
| 23 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.56595313 |
| 24 | Bile secretion_Homo sapiens_hsa04976 | 1.51417126 |
| 25 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.47980487 |
| 26 | Leishmaniasis_Homo sapiens_hsa05140 | 1.46101852 |
| 27 | Phagosome_Homo sapiens_hsa04145 | 1.45427438 |
| 28 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.44712021 |
| 29 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.40633642 |
| 30 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.40280386 |
| 31 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.39956298 |
| 32 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.39880686 |
| 33 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.29215028 |
| 34 | ABC transporters_Homo sapiens_hsa02010 | 1.27976425 |
| 35 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.27303883 |
| 36 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.27267484 |
| 37 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.26735635 |
| 38 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.25302421 |
| 39 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.25062817 |
| 40 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.17145894 |
| 41 | Salmonella infection_Homo sapiens_hsa05132 | 1.17084138 |
| 42 | Hepatitis B_Homo sapiens_hsa05161 | 1.14042255 |
| 43 | Allograft rejection_Homo sapiens_hsa05330 | 1.13508264 |
| 44 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.13062274 |
| 45 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.12112726 |
| 46 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.09390930 |
| 47 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.08464459 |
| 48 | Retinol metabolism_Homo sapiens_hsa00830 | 1.07494803 |
| 49 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.07423026 |
| 50 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.05805146 |
| 51 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.05489182 |
| 52 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.03877444 |
| 53 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.02972838 |
| 54 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.99930707 |
| 55 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.96665334 |
| 56 | Shigellosis_Homo sapiens_hsa05131 | 0.94747805 |
| 57 | Apoptosis_Homo sapiens_hsa04210 | 0.93557668 |
| 58 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.92185290 |
| 59 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.91681163 |
| 60 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.90987760 |
| 61 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.90721712 |
| 62 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.89581513 |
| 63 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.89449606 |
| 64 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.88663223 |
| 65 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.87995019 |
| 66 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.86938530 |
| 67 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.85713179 |
| 68 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.85133081 |
| 69 | Platelet activation_Homo sapiens_hsa04611 | 0.83687291 |
| 70 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.82465514 |
| 71 | Pertussis_Homo sapiens_hsa05133 | 0.82147349 |
| 72 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.81099159 |
| 73 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.79739459 |
| 74 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.79330383 |
| 75 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.79131211 |
| 76 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.78736118 |
| 77 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.77744293 |
| 78 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.77237953 |
| 79 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.76514182 |
| 80 | Measles_Homo sapiens_hsa05162 | 0.76362238 |
| 81 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.76132625 |
| 82 | Legionellosis_Homo sapiens_hsa05134 | 0.75787047 |
| 83 | Sulfur relay system_Homo sapiens_hsa04122 | 0.75326729 |
| 84 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.74407187 |
| 85 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.74336845 |
| 86 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.73825564 |
| 87 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.72276631 |
| 88 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.71615819 |
| 89 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.68962032 |
| 90 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.68113682 |
| 91 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.67756244 |
| 92 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.67053652 |
| 93 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.66593708 |
| 94 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.66466349 |
| 95 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.66139688 |
| 96 | Tuberculosis_Homo sapiens_hsa05152 | 0.65323644 |
| 97 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.64803171 |
| 98 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.64669769 |
| 99 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.64661632 |
| 100 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.64566864 |
| 101 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.63914994 |
| 102 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.62423104 |
| 103 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.62106933 |
| 104 | Endocytosis_Homo sapiens_hsa04144 | 0.61262396 |
| 105 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.60794938 |
| 106 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.60014088 |
| 107 | Malaria_Homo sapiens_hsa05144 | 0.59601024 |
| 108 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.59537551 |
| 109 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.59169313 |
| 110 | Hepatitis C_Homo sapiens_hsa05160 | 0.59152275 |
| 111 | Influenza A_Homo sapiens_hsa05164 | 0.58734186 |
| 112 | Insulin resistance_Homo sapiens_hsa04931 | 0.58606317 |
| 113 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.58305121 |
| 114 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.57937226 |
| 115 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.57549833 |
| 116 | Lysosome_Homo sapiens_hsa04142 | 0.56819015 |
| 117 | Carbon metabolism_Homo sapiens_hsa01200 | 0.56739438 |
| 118 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.56253695 |
| 119 | Amoebiasis_Homo sapiens_hsa05146 | 0.55038400 |
| 120 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.55036709 |
| 121 | HTLV-I infection_Homo sapiens_hsa05166 | 0.54930002 |
| 122 | Mineral absorption_Homo sapiens_hsa04978 | 0.53885350 |
| 123 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.52875998 |
| 124 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.51848005 |
| 125 | Other glycan degradation_Homo sapiens_hsa00511 | 0.51332621 |
| 126 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.51215721 |
| 127 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.50643841 |
| 128 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.48641190 |
| 129 | Bladder cancer_Homo sapiens_hsa05219 | 0.48207819 |
| 130 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.48205996 |
| 131 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.47873568 |
| 132 | Lysine degradation_Homo sapiens_hsa00310 | 0.47277575 |
| 133 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.46151862 |
| 134 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.45297318 |
| 135 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.43460029 |
| 136 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.42736147 |
| 137 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.42179186 |
| 138 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.41737387 |
| 139 | Prion diseases_Homo sapiens_hsa05020 | 0.40786431 |
| 140 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.40516066 |
| 141 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.40490347 |
| 142 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.40256370 |
| 143 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.40069853 |
| 144 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.39803178 |
| 145 | Endometrial cancer_Homo sapiens_hsa05213 | 0.39241086 |
| 146 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.37345028 |
| 147 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.37174647 |
| 148 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.37170249 |
| 149 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.36849929 |
| 150 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.36722475 |
| 151 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.35160484 |
| 152 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.34161505 |
| 153 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.33180023 |
| 154 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.30709419 |
| 155 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.29969978 |
| 156 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.29737820 |
| 157 | Prostate cancer_Homo sapiens_hsa05215 | 0.26521212 |
| 158 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.25054788 |
| 159 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.24125657 |

